GSK’s Shingrix vaccine gets positive CHMP opinion for prefilled syringe
PositiveFinancial Markets

GSK's Shingrix vaccine has received a positive opinion from the CHMP for its new prefilled syringe format, which is a significant step forward in making vaccination more accessible and convenient for patients. This development is important as it could enhance the uptake of the vaccine, ultimately helping to protect more individuals from shingles.
— Curated by the World Pulse Now AI Editorial System